Notice of Intent to Sole Source. One Molecular Devices BioAssemblyBot (BAB) 400

The Department of the Interior, Interior Business Center, is preparing to sole-source one Molecular Devices BioAssemblyBot (BAB) 400 system for the National Institute of Allergy and Infectious Diseases, with responses to the notice of intent due by 10 a.m. ET on August 5, 2026. This is a sole-source acquisition with no set-aside. Vendors interested in proposing alternative instruments may submit responses limited to two pages, including vendor name, UEI, size standard information, instrument description demonstrating salient characteristics, reseller availability and UEI numbers, and availability through government-wide vehicles such as GSA Federal Supply Schedules.

The BAB400 is an advanced robotic cell-culture and bioprinting platform featuring a six-axis robotic arm with interchangeable tool hands, AI-enabled workflow orchestration via BioApps Studio software, a 44-plate incubator for continuous unattended culture storage, a brightfield/fluorescence plate imager for non-destructive cell monitoring, and a single-cell organoid dispense hand for precise standardized seeding. Required capabilities include integrated robotic liquid handling, automated temperature-controlled processing, precision single-cell and organoid handling with impedance-based detection, and automated quality control with continuous multimodal imaging and workflow traceability.

The Government requires full onsite installation, training, software, preventive maintenance, and comprehensive service support for three years. Responses should be sent to melissa_onyszko@ibc.doi.gov. The Government will not reimburse vendors for response preparation fees, and a request for quote for competitive offerors is not guaranteed. NAICS 334516, PSC 6640.